Jürgen Pohle

Chief Executive Officer and General Manager

Biography >

In his role, he leads the global commercial organisation for further growth and development of products. Mr Pohle joined Neovii in 2016 bringing over 25 years of experience in the pharmaceutical industry. Prior to joining Neovii, he held senior leadership positions at GSK, Novartis and Bayer HealthCare. Mr Pohle holds a law degree from University of Cologne, Germany.

Alfred Doucette

Chief Financial Officer

Biography >

With more than 20 years of experience in the pharmaceutical industry, Mr. Doucette joined the company in 2018. Previously, he held senior international finance and commercial positions in Wyeth Pharmaceuticals, later acquired by Pfizer Inc. His most recent role was Regional Commercial Director SEE/Turkey/Greece/Israel for Pfizer’s Consumer Healthcare business unit. Mr. Doucette holds a degree in business administration from Vienna University of Economics and Business.

John Petan MD

Vice President and Chief Medical Officer

Biography >

Dr Petan has 20 years experience in the pharmaceutical industry including VP of Medical and Development Division at Astellas China, Senior Director at Genzyme Europe and Director Medical Affairs at Fresenius Biotech as well as at Astellas Europe.  In addition to his medical degrees from Colombia and Germany, Dr Petan has an Executive MBA degree from the Instituto de Empresa, Spain.

Dr Christian Loss

Vice President, Managing Director & Country Head Germany

Biography >

Dr Loss leads the company’s global manufacturing operations (Neovii Biotech GmBH) and as well as commercial & development operations for Germany. Dr. Loss joined the company in 2009 from Fresenius Biotech where he served as Vice-President and Head of Business Unit. Dr. Loss has in addition worked for international, industrial and consulting companies. He holds a PhD in business economics from the University of St. Gallen, Switzerland.

Frank Glavin

Vice President and Head of North America

Biography >

In this role, he oversees the group’s strategy, clinical and commercial development, and operations for North America. Mr Glavin brings over 15 years of drug and commercial development experience in both public and private companies to Neovii. Previously he was the Director of Therapeutics at CombinatoRx where he spearheaded translational drug development. Prior to that, Mr Glavin was part of the Serono Strategic Planning team and was a Life Science Management Consultant developing new-business incubation, in-licensing and acquisition, and franchise development strategies for global pharmaceutical and health care clients. Mr Glavin has a B.S. in Human Physiology from Boston University as well as an MBA from the Johnson Graduate School of Management at Cornell University.

Dr Richard Sachse, MD, PhD

Chief Scientific Officer

Biography >

Dr. Sachse leads Neovii’s Global Scientific Department comprising all regulatory, medical, and development activities globally. He joined Neovii in 2018 bringing over 20 years of experience in the pharmaceutical industry incl. senior leadership positions in Aeterna Zentaris, Boehringer Ingelheim, UCB, Schwarz Pharma, Peptor and Bayer. Dr. Sachse is a physician experienced in Internal Medicine and holds a board certification in Clinical Pharmacology.